Open original FDA record ↗Recall record
- FDA identifier
- Z-2089-2012
- Company in FDA record
- Stryker Howmedica Osteonics Corp.
- FDA classification date
- Jul 26, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
Stryker has updated the instruction for use (IFU) (product correction)for the ABGII Modular and Rejuvenate Modular Hip Systems. This is based on a reported rate of less than one percent for revisions potentially associated with fretting and or corrosion at or about the modular neck junction. On June 29, 2012, Stryker has decided to remove the affected product from the field since there may be an
Source facts
- Action
- Stryker sent an "URGENT PRODUCT CORRECTION" letter dated April 23, 2012 to all affected customers. The letter identifies the product, problem, and actions to be taken by the customers. The letter included a Product Correction Acknowledgment Form for customers to complete and return via fax to 201-831-6069. Contact the firm at 201-831-5970 for questions regarding this notice. Stryker sent and "Urgent Update Product Recall" Letter dated January 3, 2013 to all affected customers. The new letter includes updated corrective actions for patients. Another letter was sent out on 7/25/2014.
- Initiated
- 2012-04-30
- Root cause
- Device Design
- Distribution
- Nationwide Distribution
- Recall number
- Z-2089-2012
- Recall status
- Open, Classified
- CDRH record ID
- 110697
- FDA classified
- 2012-07-26
- Recall event number
- 62456